Peijia Medical Limited (HKG:9996)

Peijia Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	601.77	666.74	795.77	1,670	2,296	2,458
Short-Term Investments	-	31.04	70	1.87	1.93	2.14
Trading Asset Securities	-	14.75	77.16	71.56	-	3.26
Cash & Short-Term Investments	601.77	712.52	942.93	1,743	2,298	2,464
Cash Growth	-35.27%	-24.44%	-45.91%	-24.15%	-6.72%	373.32%
Accounts Receivable	58.7	101.04	80.21	12.6	-	-
Other Receivables	-	-	-	63.26	31.41	40.6
Receivables	58.7	101.04	80.21	75.86	31.41	40.6
Inventory	136.98	156.8	170.65	173.19	85.97	35.58
Other Current Assets	30.03	16.64	43.71	15.3	10.95	4.32
Total Current Assets	827.48	987	1,237	2,007	2,426	2,544
Property, Plant & Equipment	746.67	695.76	498.61	327.44	176.22	107.35
Long-Term Investments	340.67	326.81	387.06	415.49	224.42	-
Goodwill	51.66	51.66	51.66	51.66	51.66	51.66
Other Intangible Assets	586.69	604.34	476.22	487.29	224.84	162.06
Other Long-Term Assets	7.7	23.14	20.94	13.33	60.16	16.12
Total Assets	2,601	2,689	2,672	3,316	3,164	2,881
Accounts Payable	38.72	25.72	19.71	361.58	54.17	8.13
Accrued Expenses	67.21	50.65	53	50.48	24.49	14.96
Short-Term Debt	224.53	89.78	13.83	56.06	-	-
Current Portion of Leases	2.8	2.09	2.59	2.89	3.55	9.13
Current Income Taxes Payable	-	1.27	-	15.27	5.39	-
Current Unearned Revenue	-	-	-	-	-	0.71
Other Current Liabilities	129.95	273.19	65.12	91.75	31.12	11.47
Total Current Liabilities	463.22	442.7	154.25	578.02	118.71	44.39
Long-Term Debt	91.2	158.31	203.59	70.77	-	-
Long-Term Leases	3.75	3.22	1.13	2.15	4.08	-
Long-Term Unearned Revenue	19.96	20.77	13.1	1.72	1.37	3.28
Long-Term Deferred Tax Liabilities	14.5	16.78	20.32	20.32	20.32	20.32
Other Long-Term Liabilities	22.02	2.32	5.49	5.87	-	-
Total Liabilities	614.64	644.11	397.88	678.86	144.48	67.99
Common Stock	0.47	0.47	0.48	0.48	0.47	0.45
Additional Paid-In Capital	6,320	6,323	6,359	6,369	6,339	5,512
Retained Earnings	-	-	-	-3,713	-3,305	-2,731
Treasury Stock	-	-	-	-82.74	-84.55	-23.13
Comprehensive Income & Other	-4,351	-4,296	-4,085	63.62	69.14	54.41
Total Common Equity	1,969	2,028	2,274	2,638	3,019	2,813
Minority Interest	17.21	16.56	-0.03	-	-	-
Shareholders' Equity	1,986	2,045	2,274	2,638	3,019	2,813
Total Liabilities & Equity	2,601	2,689	2,672	3,316	3,164	2,881
Total Debt	322.28	253.4	221.14	131.88	7.63	9.13
Net Cash (Debt)	279.49	459.12	721.79	1,611	2,290	2,454
Net Cash Growth	-58.72%	-36.39%	-55.20%	-29.65%	-6.68%	-
Net Cash Per Share	0.42	0.69	1.06	2.39	3.46	5.26
Filing Date Shares Outstanding	666.73	665.19	675.51	672.2	666.69	631.84
Total Common Shares Outstanding	666.73	665.19	675.51	672.2	666.69	631.84
Working Capital	364.27	544.3	1,083	1,429	2,308	2,500
Book Value Per Share	2.95	3.05	3.37	3.92	4.53	4.45
Tangible Book Value	1,331	1,372	1,746	2,099	2,743	2,600
Tangible Book Value Per Share	2.00	2.06	2.59	3.12	4.11	4.11
Buildings	434.15	433.17	61.97	53.56	53.53	53.53
Machinery	188.47	184.28	152.79	109.64	76.51	41.48
Construction In Progress	178.34	122.31	290.45	167.41	28.61	1.05
Leasehold Improvements	53.85	40.72	39.11	38.6	31.06	17.9

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.